A combined chemical-physical treatment for herpes simplex lesions in guinea pigs.
Determination of the effectiveness of chemical treatments for Herpes simplex type 2 infections has generally relied on a reduction in the rate of mortality. A more natural progression of the disease is seen when non-progressive cutaneous lesions are induced. Treatment of characteristic cutaneous lesions with ultrasound alone, a cream compound designated Herpigon alone, or a combination of ultrasound and Herpigon were compared to determine the time required for lesions to heal and the amount of virus recoverable from treated lesions. Results indicate that the use of Herpigon alone or in combination with ultrasound resulted in a significant reduction in the time required for the lesions to heal. A comparison of the amount of virus present in treated lesions indicated that the combined treatment was most effective in reducing the amount of recoverable virus.
D000818:Animals; D006168:Guinea Pigs; D006561:Herpes Simplex / Q000188:drug therapy / Q000628:therapy*; D047348:Hydrolyzable Tannins / Q000627:therapeutic use*; D008297:Male; D009824:Ointments; D013634:Tannins / Q000627:therapeutic use*; D014464:Ultrasonic Therapy; D014508:Urea / Q000627:therapeutic use*; D015032:Zinc / Q000627:therapeutic use*
D047348:Hydrolyzable Tannins; D009824:Ointments; D013634:Tannins; D014508:Urea; D015032:Zinc